Status:

COMPLETED

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

Lead Sponsor:

Organon and Co

Conditions:

Dysmenorrhea

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).

Eligibility Criteria

Inclusion

  • Women 18 years of age or older suffering from painful menstruation

Exclusion

  • Women taking medications that are not allowed in the study (such as pain medications, antidepressants, tranquilizers, hypnotics, sedatives, or oral contraceptives).
  • Women who are pregnant, breast-feeding or within 6 weeks of giving birth

Key Trial Info

Start Date :

June 7 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 6 2002

Estimated Enrollment :

129 Patients enrolled

Trial Details

Trial ID

NCT00092729

Start Date

June 7 2002

End Date

December 6 2002

Last Update

August 15 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.